Literature DB >> 1521508

Physiology of growth hormone secretion and action.

F F Casanueva1.   

Abstract

Growth hormone secretion by the pituitary gland is dependent on the dual regulation exerted by growth hormone-releasing hormone and somatostatin, which are the final integrative pathways for several signals reaching the hypothalamus. Regulatory signals include neurotransmitters, neuropeptides, and peripheral signals such as hormones or nutrients. In the circulation, growth hormone is bound to specific binding proteins and, by activating specific receptors, exerts a variety of peripheral actions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521508

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  21 in total

1.  Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns?

Authors:  G Pittoni; G Gallioi; M Zanello; L Gianotti; M F Boghen; S Colombo; F Broglio; C Santoro; G Davià; M G Papini; S Destefanis; F Minuto; C Miola; E Ghigo
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 2.  Ghrelin: the link connecting growth with metabolism and energy homeostasis.

Authors:  Felipe F Casanueva; Carlos Dieguez
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

3.  Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditions.

Authors:  L Gianotti; F Broglio; G Aimaretti; E Arvat; S Colombo; M Di Summa; G Gallioli; G Pittoni; E Sardo; M Stella; M Zanello; C Miola; E Ghigo
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

4.  Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man.

Authors:  E Arvat; B Maccagno; J Ramunni; L Gianotti; L Di Vito; R Deghenghi; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

5.  Oral arginine improves linear growth of long bones and the neuroendocrine mechanism.

Authors:  Ming-Yu Jiang; De-Pei Cai
Journal:  Neurosci Bull       Date:  2011-06       Impact factor: 5.203

6.  Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system.

Authors:  L M Seoane; O Al-Massadi; F Barreiro; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

7.  The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE).

Authors:  Julia A Schantl; Marcel Roza; Peter Van Kerkhof; Ger J Strous
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

8.  Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans.

Authors:  A Benso; C Gottero; F Prodam; C Gauna; S Destefanis; L Filtri; A J van der Lely; R Deghenghi; E Ghigo; F Broglio
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

9.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

10.  A technique of mRNA extraction and labeling from circulating lymphocytes of children treated with growth hormone replacement therapy for microarray analysis.

Authors:  M Camilot; F Teofoli; S Longobardi; A Gandini; C Lievore; S Lauriola; L Tatò
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.